Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
1,857.00
-21.00 (-1.12%)
Nov 13, 2026, 3:30 PM JST

Fuji Pharma Cash Flow Statement

Millions JPY. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Income
3,1554,0008,2764,3993,723
Depreciation & Amortization
4,2073,9653,6803,0232,745
Loss (Gain) From Sale of Assets
762394-41
Loss (Gain) From Sale of Investments
2,000--3,118--
Other Operating Activities
-1,749-2,193-1,027-941-1,504
Change in Accounts Receivable
-2,528525-1,997-3,705-549
Change in Inventory
-1,294-3,0781,552-3,395-3,618
Change in Accounts Payable
-895356-1,640-652447
Change in Other Net Operating Assets
2,5161,832-1,5753,184-1,903
Operating Cash Flow
6,1745,8014,1511,917-658
Operating Cash Flow Growth
6.43%39.75%116.54%--

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Capital Expenditures
-2,092-1,981-2,778-3,327-5,097
Sale of Property, Plant & Equipment
522101,383
Sale (Purchase) of Intangibles
-1,806-1,873-1,594-570-7,326
Investment in Securities
--5,356--
Other Investing Activities
263-367-2,644-1,353-231
Investing Cash Flow
-3,630-4,219-1,658-5,240-11,271

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Short-Term Debt Issued
--4,0003,0001,300
Long-Term Debt Issued
-9,987-2,9857,300
Total Debt Issued
-9,9874,0005,9858,600
Long-Term Debt Repaid
-1,981-7,749-5,210-2,740-2,140
Net Debt Issued (Repaid)
-1,9812,238-1,2103,2456,460
Issuance of Common Stock
3,30021055--
Common Dividends Paid
-1,225-1,036-972-899-729
Other Financing Activities
-523-4581,692-431-637
Financing Cash Flow
-429954-4351,9155,094

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Foreign Exchange Rate Adjustments
135123202185183
Miscellaneous Cash Flow Adjustments
-1-2-1
Net Cash Flow
2,2502,6602,260-1,221-6,653

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Free Cash Flow
4,0823,8201,373-1,410-5,755
Free Cash Flow Growth
6.86%178.22%---
Free Cash Flow Margin
6.54%7.39%2.98%-3.45%-16.25%
Free Cash Flow Per Share
160.31156.5456.48-58.02-236.90
Levered Free Cash Flow
1,881535.5599.13-4,258-11,724
Unlevered Free Cash Flow
2,131741.75721.63-4,182-11,676

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash Interest Paid
39332719410482
Cash Income Tax Paid
1,7572,1971,0269461,498
Change in Working Capital
-2,201-365-3,660-4,568-5,623